Acetazolamide (All indications)

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)24.39 [2.95, 201.78]0%3 studies1454not evaluable ROB48.27 [5.34; .]
Major congenital malformations24.39 [2.95, 201.78]0%3 studies1454not evaluable ROB48.27 [5.34; .]
Microcephaly / Small head circumference for gestational age0.13 [0.01, 2.05]-1 study134,023127not evaluable ROB-

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Small for gestational age (weight)1.00 [0.58, 1.73]-1 study446,282127not evaluable ROB-

Hide endpoints reported in only one study ...